A Double-Blind, Randomized, Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of Standard Dose Quadrivalent Inactivated Influenza Vaccine, and Double Dose Quadrivalent Inactivated Influenza Vaccine in HIV-Infected and HIV-Uninfected Pregnant Women in a Malaria-Endemic Area of Rural Western Kenya

Trial Profile

A Double-Blind, Randomized, Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of Standard Dose Quadrivalent Inactivated Influenza Vaccine, and Double Dose Quadrivalent Inactivated Influenza Vaccine in HIV-Infected and HIV-Uninfected Pregnant Women in a Malaria-Endemic Area of Rural Western Kenya

Withdrawn prior to enrolment
Phase of Trial: Phase II/III

Latest Information Update: 12 Jun 2014

At a glance

  • Drugs Influenza virus vaccine (Primary) ; Poliovirus vaccine inactivated; Poliovirus vaccine inactivated
  • Indications Influenza virus infections; Poliomyelitis
  • Focus Adverse reactions; Pharmacodynamics; Registrational
  • Most Recent Events

    • 08 Apr 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to withdrawn prior to recruitment.
    • 30 Jan 2014 Planned number of patients changed from 960 to 720 as reported by ClinicalTrials.gov
    • 08 Jan 2014 Protocol has been amended with changes in official title, endpoints, treatment table, planned patient number.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top